BD 2652015 - PowerLoc PAK Safety Infusion Set, 20G x 1.5", Without Y-Injection Site", 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

BD 2652015 - PowerLoc PAK Safety Infusion Set, 20G x 1.5", Without Y-Injection Site", 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

The BD 2652015 PowerLoc PAK Safety Infusion Set is a sterile, single-use port-access solution designed for accessing compatible surgically implanted vascular ports. The set features a 20-gauge non-coring needle with a 1.5-inch length and is configured without a Y-injection site, providing a streamlined direct fluid pathway for compatible infusion and vascular-access procedures.

The PowerLoc system supports administration of compatible medications and fluids, blood specimen collection, implanted port flushing, and power injection through appropriately rated vascular access systems. The 20-gauge configuration provides a practical balance between needle diameter and flow capability for a wide range of infusion therapy and diagnostic imaging applications.

The 1.5-inch needle length is designed for implanted ports positioned beneath a greater depth of subcutaneous tissue. Proper needle-length selection helps provide complete septum access while supporting secure positioning, effective dressing application, and appropriate management of deeper implanted ports.

Because BD 2652015 does not include a Y-injection site, it provides a direct infusion pathway without an integrated secondary access point. This configuration may be preferred for clinical workflows where a single primary connection is appropriate and secondary medication or fluid access through the tubing is not required.

The PowerLoc platform incorporates passive needle-tip safety designed to help reduce accidental needlestick exposure during port deaccessing. Its low-profile, lightweight design, small footprint, ergonomic wings, and access-site visibility support efficient port management and dressing application.

The PAK presentation provides an organized, all-in-one solution intended to simplify the multi-step sterile preparation process for implanted port access. BD 2652015 is supplied five sets per case.

Key Benefits

• 20-gauge non-coring needle supports access to compatible surgically implanted vascular ports.
• 1.5-inch needle length accommodates ports positioned beneath greater subcutaneous tissue depth.
• Power-injectable design supports compatible contrast-enhanced diagnostic imaging procedures.
• Corresponding 20-gauge PowerLoc configurations support power-injection flow rates up to 5 mL per second when the complete vascular-access system is appropriately rated.
• Configuration without a Y-injection site provides a streamlined direct fluid pathway.
• Non-coring needle design helps minimize unnecessary damage to the implanted port septum during appropriate access.
• Passive needle-tip safety helps reduce accidental sharps exposure during deaccessing.
• Audible and visual safety lockout indicators support confirmation of safety activation.
• Low-profile design helps facilitate secure dressing application.
• Small footprint supports improved visibility around the port-access site.
• Lightweight construction helps reduce unnecessary bulk at the access site.
• Ergonomic wing design supports controlled access and site visibility.
• Downward-angled tubing helps support dressing integrity.
• Compatible with appropriate dual-lumen implanted port applications.
• Suitable for compatible infusion therapy, blood sampling, port maintenance, and power-injection workflows.
• PAK configuration helps organize supplies used during sterile port-access preparation.
• Five-per-case packaging supports efficient clinical inventory management.

Compatibility and Applications

The BD 2652015 PowerLoc PAK Safety Infusion Set is intended for use with compatible surgically implanted vascular access ports designed to accept non-coring port-access needles.

Potential clinical applications include chemotherapy administration, antibiotic therapy, hydration, parenteral nutrition, blood product administration, long-term infusion therapy, blood specimen collection, implanted port flushing, and compatible contrast-media delivery during diagnostic imaging procedures.

The 20-gauge configuration may be selected when moderate-to-high flow capability is required while maintaining a smaller needle diameter than a 19-gauge access device. Selection should consider medication or fluid viscosity, required flow rate, implanted port specifications, infusion equipment, power-injection requirements, and professional clinical judgment.

The 1.5-inch needle length is intended for deeper implanted ports or patients with greater tissue depth over the port septum. A needle that is too short may not completely access the port septum, while unnecessary additional length may affect stability, dressing placement, and site management.

Because this configuration does not include a Y-injection site, it provides a direct fluid pathway without an integrated secondary medication-access point. Clinical teams should determine whether this configuration is appropriate for the planned treatment workflow before use.

For power injection, the implanted port, access needle, tubing, connectors, extension components, and every other component within the complete fluid pathway must be specifically rated for the intended procedure. The lowest-rated component determines the maximum allowable pressure and flow rate.

Compatibility should be confirmed with the exact implanted port model, septum design, tissue depth, prescribed therapy, infusion pump, power injector, connector system, dressing materials, and institutional vascular-access procedures.

Usage Guidelines

The BD 2652015 should be used only by healthcare professionals trained and authorized to access implanted vascular ports. Current manufacturer instructions, aseptic technique, institutional procedures, and the implanted port manufacturer's directions should be followed throughout the procedure.

• Confirm the patient's identity, prescribed therapy, implanted port type, and power-injection status when applicable.
• Assess the location and depth of the implanted port before selecting the 1.5-inch needle.
• Verify that the 20-gauge configuration is appropriate for the intended infusion or imaging procedure.
• Confirm that a configuration without a Y-injection site is appropriate for the planned clinical workflow.
• Inspect the sterile package for punctures, moisture, damage, contamination, or compromised integrity.
• Prepare the implanted port site according to institutional skin-antisepsis and sterile-access procedures.
• Prime the complete infusion pathway using an approved solution and aseptic technique.
• Remove air from the fluid pathway before accessing the implanted port.
• Stabilize the implanted port and insert the non-coring needle perpendicular to the port septum using an approved technique.
• Advance the needle carefully until appropriate access to the port reservoir is achieved.
• Verify correct needle placement according to institutional policy, including aspiration for blood return when clinically appropriate.
• Flush the implanted port according to current manufacturer instructions and facility protocol.
• Position and secure the tubing to minimize pulling, twisting, pressure, and dressing disruption.
• Apply an approved sterile dressing while maintaining appropriate access-site visibility.
• Monitor the site for pain, swelling, redness, leakage, displacement, or other abnormalities throughout therapy.
• Confirm power-injection eligibility before connecting the system to a power injector.
• Do not exceed the operating limits specified for the complete vascular-access system.
• After therapy, flush and lock the implanted port according to the prescribed protocol.
• Stabilize the port while withdrawing the needle and allowing the passive safety mechanism to engage.
• Confirm safety lockout before further handling of the device.
• Dispose of the used device immediately in an approved sharps container.

Stop the procedure and assess the vascular-access system if unexpected resistance occurs during flushing, expected blood return cannot be obtained, the patient experiences unusual discomfort, or swelling, leakage, displacement, or another abnormality develops at the port site.

Certifications and Safety Standards

The BD 2652015 PowerLoc PAK Safety Infusion Set is intended for professional medical use within established vascular-access, infusion-therapy, diagnostic imaging, infection-prevention, and occupational safety programs.

The device should be incorporated into facility procedures addressing implanted port assessment, hand hygiene, sterile preparation, skin antisepsis, port access, infusion administration, dressing management, power injection, port deaccessing, and sharps disposal.

The passive needle-tip safety mechanism is designed to help protect healthcare professionals from accidental needlestick exposure during removal of the device from an implanted port. Audible and visual indications of safety lockout help clinicians verify activation before disposal.

The safety feature does not replace appropriate clinician training, personal protective equipment, safe sharps-handling practices, exposure-control procedures, or immediate disposal in an approved sharps container.

The non-coring needle is designed for accessing compatible implanted vascular port septa while helping minimize unnecessary septum damage during appropriate use. Needle gauge and length should be selected according to patient anatomy, tissue depth, implanted port specifications, prescribed therapy, and required flow characteristics.

Healthcare organizations should review current manufacturer documentation for applicable FDA status, UDI information, sterilization method, material composition, natural rubber latex status, DEHP information, shelf life, pressure limitations, flow-rate specifications, warnings, precautions, and other technical or regulatory requirements.

Comparison with Competitors

Compared with conventional implanted port needles without integrated safety technology, the BD PowerLoc system incorporates passive needle-tip protection designed to help reduce accidental needlestick exposure during deaccessing and disposal.

Compared with PowerLoc configurations containing a Y-injection site, BD 2652015 provides a direct fluid pathway without an integrated secondary access point. This may simplify the tubing configuration when secondary medication or fluid administration through a Y-site is not required.

Compared with non-power-injectable port-access devices, the PowerLoc platform supports compatible power-injection procedures when used with an appropriately rated implanted port and complete fluid pathway.

Compared with a 19-gauge PowerLoc configuration, the 20-gauge needle offers a smaller external diameter while maintaining substantial flow capability for many infusion and imaging applications. Compared with a 22-gauge configuration, the 20-gauge option may be preferred when greater flow capability is required.

Compared with 0.75-inch and 1-inch access needles, the 1.5-inch configuration accommodates implanted ports positioned beneath greater tissue depth. Correct needle-length selection is important because insufficient length may prevent complete septum access, while unnecessary additional length may affect device stability.

Compared with loose individual port-access supplies, the PAK presentation provides an organized solution for the multi-step sterile preparation process. This can help simplify supply preparation and support procedural consistency across clinical teams.

Alternative safety infusion sets may differ in gauge, needle length, power-injection capability, safety activation method, tubing design, Y-site availability, kit contents, and packaging quantity. BD 2652015 combines a 20-gauge, 1.5-inch non-coring needle with a direct no-Y-site configuration, passive safety technology, power-injection capability, and organized PAK presentation.

Typical User Profile and Application Scenarios

The BD 2652015 PowerLoc PAK Safety Infusion Set is intended for trained healthcare professionals responsible for accessing and managing implanted vascular ports. Typical users include infusion nurses, oncology nurses, radiology nurses, vascular-access specialists, physicians, advanced practice clinicians, and other qualified healthcare personnel.

Common use environments include hospitals, oncology centers, outpatient infusion clinics, diagnostic imaging departments, ambulatory treatment centers, emergency departments, specialty practices, and other healthcare facilities where implanted vascular ports are routinely accessed.

The product may be selected for patients whose implanted port requires a longer 1.5-inch access needle because of tissue depth or port position and whose prescribed therapy or diagnostic procedure is compatible with a 20-gauge access device.

Typical application scenarios include chemotherapy administration, antibiotic infusion, hydration, parenteral nutrition, blood product administration, blood specimen collection, routine implanted port maintenance, and compatible power-injection procedures during diagnostic imaging.

The configuration without a Y-injection site is particularly relevant for clinical workflows using a direct primary connection that do not require an integrated secondary medication or fluid-access point.

Best Practices for Use and Maintenance

The BD 2652015 is a sterile, single-use medical device and does not require maintenance as reusable equipment. Best practices focus on proper storage, accurate product selection, sterile preparation, implanted port access, site monitoring, power-injection verification, safety activation, and disposal.

• Store unopened sets according to manufacturer-recommended environmental conditions.
• Protect packages from moisture, excessive temperatures, crushing, punctures, and contamination.
• Rotate inventory according to expiration dates and facility stock-control procedures.
• Verify the BD 2652015 catalog number before opening the package.
• Confirm the 20-gauge size, 1.5-inch needle length, and configuration without a Y-injection site.
• Assess the patient's tissue depth and implanted port position before selecting the needle length.
• Confirm that the prescribed therapy, fluid characteristics, and required flow rate are appropriate for a 20-gauge access device.
• Use strict aseptic technique during preparation, priming, insertion, connection, and dressing application.
• Prime the complete fluid pathway before accessing the implanted vascular port.
• Stabilize the implanted port during both needle insertion and removal.
• Position the tubing to minimize pulling, twisting, or pressure at the access site.
• Monitor the implanted port site and tubing connections throughout therapy.
• Verify that the entire vascular-access system is appropriately rated before any power-injection procedure.
• Follow the lowest pressure and flow-rate limit of any component within the complete system.
• Do not bend, cut, modify, repair, or otherwise alter the infusion set.
• Do not reuse, clean, resterilize, or reprocess the single-use device.
• Confirm complete safety activation immediately after needle withdrawal.
• Place the protected device directly into an approved sharps container.

Regulatory and Safety Information

The BD 2652015 PowerLoc PAK Safety Infusion Set should be used only by appropriately trained healthcare professionals and only for applications consistent with current manufacturer labeling, implanted port instructions, professional clinical judgment, and institutional policy.

Before use, verify the product identity, 20-gauge size, 1.5-inch needle length, no-Y-site configuration, sterile package integrity, expiration date, and compatibility with the implanted vascular port. Do not use a device that is expired, damaged, contaminated, or supplied in compromised packaging.

The set should not be used for power injection unless the implanted port and every component within the complete fluid pathway are specifically rated for the intended procedure. Permitted pressure, flow rate, contrast-media characteristics, and other operating conditions must be confirmed before use.

The corresponding 20-gauge PowerLoc configuration without a Y-injection site is rated for power injection up to 5 mL per second under applicable manufacturer-specified conditions. The lowest-rated component within the complete vascular-access system determines the maximum allowable operating limit.

Incorrect needle-length selection, incomplete septum access, excessive pressure, needle displacement, or improper securement may contribute to infiltration, extravasation, leakage, tissue injury, implanted port damage, interrupted therapy, or other complications.

Because BD 2652015 does not include a Y-injection site, it does not provide an integrated secondary access point within the tubing. Clinical teams should confirm that a direct fluid pathway meets the requirements of the planned therapy before use.

The passive safety mechanism should be used according to current manufacturer instructions. The device remains a contaminated sharp following deaccessing and should be discarded immediately in an approved sharps container.

BD 2652015 is supplied five sets per case with a minimum order quantity of one case according to the manufacturer listing. Purchasing personnel should confirm current availability, shipping eligibility, storage requirements, order quantity, and applicable return conditions before purchasing.

How to Order

Select the BD 2652015 - PowerLoc PAK Safety Infusion Set without Y-Injection Site, 20G x 1.5" and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.